{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T12:44:12Z","timestamp":1792327452708,"version":"4.4.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T00:00:00Z","timestamp":1792281600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T00:00:00Z","timestamp":1792281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"DOI":"10.1038\/s41433-026-04986-0","type":"journal-article","created":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T12:14:22Z","timestamp":1792325662000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Imaging biomarkers in diabetic macular oedema: Predicting vision beyond retinal thickness"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2815-5031","authenticated-orcid":false,"given":"Enrico","family":"Borrelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,18]]},"reference":[{"key":"4986_CR1","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.ophtha.2011.12.039","volume":"119","author":"QD Nguyen","year":"2012","unstructured":"Nguyen QD, Brown DM, Marcus DM, Boyer DS, Patel S, Feiner L, et al. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology. 2012;119:789\u2013801. https:\/\/doi.org\/10.1016\/j.ophtha.2011.12.039.","journal-title":"Ophthalmology"},{"key":"4986_CR2","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1016\/j.ophtha.2015.06.017","volume":"122","author":"DM Brown","year":"2015","unstructured":"Brown DM, Schmidt-Erfurth U, Do DV, Holz FG, Boyer DS, Midena E, et al. Intravitreal aflibercept for diabetic macular edema: 100-week results from the VISTA and VIVID studies. Ophthalmology. 2015;122:2044\u201352. https:\/\/doi.org\/10.1016\/j.ophtha.2015.06.017.","journal-title":"Ophthalmology"},{"key":"4986_CR3","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.ophtha.2006.06.052","volume":"114","author":"N Diabetic Retinopathy Clinical Resea","year":"2007","unstructured":"Diabetic Retinopathy Clinical Research N, Browning DJ, Glassman AR, Aiello LP, Beck RW, Brown DM, et al. Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology. 2007;114:525\u201336. https:\/\/doi.org\/10.1016\/j.ophtha.2006.06.052.","journal-title":"Ophthalmology"},{"key":"4986_CR4","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1016\/j.ophtha.2010.03.051","volume":"117","author":"T Alasil","year":"2010","unstructured":"Alasil T, Keane PA, Updike JF, Dustin L, Ouyang Y, Walsh AC, et al. Relationship between optical coherence tomography retinal parameters and visual acuity in diabetic macular edema. Ophthalmology. 2010;117:2379\u201386. https:\/\/doi.org\/10.1016\/j.ophtha.2010.03.051.","journal-title":"Ophthalmology"},{"key":"4986_CR5","unstructured":"Alhelaly M, Quarta A, Abbasgholizadeh R, et al. Predicting visual acuity change by OCT and OCTA biomarkers in diabetic macular edema: a KINGFISHER study analysis. Eye. 2026 (in press)."},{"key":"4986_CR6","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1001\/jamaophthalmol.2023.5248","volume":"141","author":"RP Singh","year":"2023","unstructured":"Singh RP, Barakat MR, Ip MS, Wykoff CC, Eichenbaum DA, Joshi S, et al. Efficacy and safety of brolucizumab for diabetic macular edema: the KINGFISHER randomized clinical trial. JAMA Ophthalmol. 2023;141:1152\u201360. https:\/\/doi.org\/10.1001\/jamaophthalmol.2023.5248.","journal-title":"JAMA Ophthalmol"},{"key":"4986_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ophtha.2025.07.038","volume":"133","author":"K Nanji","year":"2026","unstructured":"Nanji K, Grad J, Hatamnejad A, El-Sayes A, Mihalache A, Gemae M, et al. Baseline OCT biomarkers associated with visual acuity in diabetic macular edema: a systematic review and meta-analysis. Ophthalmology. 2026;133:75\u201390. https:\/\/doi.org\/10.1016\/j.ophtha.2025.07.038.","journal-title":"Ophthalmology"},{"key":"4986_CR8","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ajo.2021.09.002","volume":"235","author":"E Borrelli","year":"2022","unstructured":"Borrelli E, Grosso D, Barresi C, Lari G, Sacconi R, Senni C, et al. Long-term visual outcomes and morphologic biomarkers of vision loss in eyes with diabetic macular edema treated with anti-VEGF therapy. Am J Ophthalmol. 2022;235:80\u201389. https:\/\/doi.org\/10.1016\/j.ajo.2021.09.002.","journal-title":"Am J Ophthalmol"},{"key":"4986_CR9","doi-asserted-by":"publisher","first-page":"101220","DOI":"10.1016\/j.preteyeres.2023.101220","volume":"98","author":"SK Szeto","year":"2024","unstructured":"Szeto SK, Lai TY, Vujosevic S, Sun JK, Sadda SR, Tan G, et al. Optical coherence tomography in the management of diabetic macular oedema. Prog Retin Eye Res. 2024;98:101220 https:\/\/doi.org\/10.1016\/j.preteyeres.2023.101220.","journal-title":"Prog Retin Eye Res"},{"key":"4986_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s40942-025-00715-z","volume":"11","author":"CK Yoon","year":"2025","unstructured":"Yoon CK, Lee HW, Kim HW, Kim JL. Deep learning based retinal hard exudates quantification of optical coherence tomography. Int J Retina Vitreous. 2025;11:114. https:\/\/doi.org\/10.1186\/s40942-025-00715-z.","journal-title":"Int J Retina Vitreous"},{"key":"4986_CR11","doi-asserted-by":"publisher","first-page":"101206","DOI":"10.1016\/j.preteyeres.2023.101206","volume":"97","author":"NK Waheed","year":"2023","unstructured":"Waheed NK, Rosen RB, Jia Y, Munk MR, Huang D, Fawzi A, et al. Optical coherence tomography angiography in diabetic retinopathy. Prog Retin Eye Res. 2023;97:101206 https:\/\/doi.org\/10.1016\/j.preteyeres.2023.101206.","journal-title":"Prog Retin Eye Res"},{"key":"4986_CR12","doi-asserted-by":"publisher","first-page":"4940","DOI":"10.1167\/iovs.16-19656","volume":"57","author":"S Zahid","year":"2016","unstructured":"Zahid S, Dolz-Marco R, Freund KB, Balaratnasingam C, Dansingani K, Gilani F, et al. Fractal dimensional analysis of optical coherence tomography angiography in eyes with diabetic retinopathy. Invest Ophthalmol Vis Sci. 2016;57:4940\u20137. https:\/\/doi.org\/10.1167\/iovs.16-19656.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4986_CR13","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1097\/IAE.0000000000003077","volume":"41","author":"E Borrelli","year":"2021","unstructured":"Borrelli E, Parravano M, Costanzo E, Sacconi R, Querques L, Pennisi F, et al. Using three-dimensional optical coherence tomography angiography metrics improves repeatability on quantification of ischemia in eyes with diabetic macular edema. Retina. 2021;41:1660\u20137. https:\/\/doi.org\/10.1097\/IAE.0000000000003077.","journal-title":"Retina"},{"key":"4986_CR14","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1159\/000515406","volume":"244","author":"CMG Cheung","year":"2021","unstructured":"Cheung CMG, Pearce E, Fenner B, Sen P, Chong V, Sivaprasad S. Looking ahead: visual and anatomical endpoints in future trials of diabetic macular ischemia. Ophthalmologica. 2021;244:451\u201364. https:\/\/doi.org\/10.1159\/000515406.","journal-title":"Ophthalmologica"},{"key":"4986_CR15","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.oret.2019.06.010","volume":"3","author":"JP Ehlers","year":"2019","unstructured":"Ehlers JP, Uchida A, Hu M, Figueiredo N, Kaiser PK, Heier JS, et al. Higher-order assessment of OCT in diabetic macular edema from the VISTA study: ellipsoid zone dynamics and the retinal fluid index. Ophthalmol Retina. 2019;3:1056\u201366. https:\/\/doi.org\/10.1016\/j.oret.2019.06.010.","journal-title":"Ophthalmol Retina"},{"key":"4986_CR16","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1001\/jamaophthalmol.2020.2130","volume":"138","author":"AR Alagorie","year":"2020","unstructured":"Alagorie AR, Nittala MG, Velaga S, Zhou B, Rusakevich AM, Wykoff CC, et al. Association of intravitreal aflibercept with optical coherence tomography angiography vessel density in patients with proliferative diabetic retinopathy: a secondary analysis of a randomized clinical trial. JAMA Ophthalmol. 2020;138:851\u20137. https:\/\/doi.org\/10.1001\/jamaophthalmol.2020.2130.","journal-title":"JAMA Ophthalmol"},{"key":"4986_CR17","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/jamaophthalmol.2017.3431","volume":"135","author":"J Lei","year":"2017","unstructured":"Lei J, Durbin MK, Shi Y, Uji A, Balasubramanian S, Baghdasaryan E, et al. Repeatability and reproducibility of superficial macular retinal vessel density measurements using optical coherence tomography angiography en face images. JAMA Ophthalmol. 2017;135:1092\u20138. https:\/\/doi.org\/10.1001\/jamaophthalmol.2017.3431.","journal-title":"JAMA Ophthalmol"},{"key":"4986_CR18","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.oret.2024.02.017","volume":"8","author":"S Tamer Kaderli","year":"2024","unstructured":"Tamer Kaderli S, Piccoli G, Limoli C, Ginelli S, Caboni S, Brotto L, et al. Clinical features related to OCT angiography artifacts in patients with diabetic macular edema. Ophthalmol Retina. 2024;8:813\u201322. https:\/\/doi.org\/10.1016\/j.oret.2024.02.017.","journal-title":"Ophthalmol Retina"},{"key":"4986_CR19","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1097\/IAE.0000000000003016","volume":"41","author":"DS Maltsev","year":"2021","unstructured":"Maltsev DS, Kulikov AN, Kazak AA, Freund KB. Suspended scattering particles in motion may influence optical coherence tomography angiography vessel density metrics in eyes with diabetic macular edema. Retina. 2021;41:1259\u201364. https:\/\/doi.org\/10.1097\/IAE.0000000000003016.","journal-title":"Retina"},{"key":"4986_CR20","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1097\/IAE.0000000000003145","volume":"41","author":"E Borrelli","year":"2021","unstructured":"Borrelli E, Sacconi R, Parravano M, Costanzo E, Querques L, Battista M, et al. Optical coherence tomography angiography assessment of the diabetic macula: a comparison study among different algorithms. Retina. 2021;41:1799\u2013808. https:\/\/doi.org\/10.1097\/IAE.0000000000003145.","journal-title":"Retina"},{"key":"4986_CR21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.oret.2017.07.003","volume":"2","author":"BG Moon","year":"2018","unstructured":"Moon BG, Um T, Lee J, Yoon YH. Correlation between deep capillary plexus perfusion and long-term photoreceptor recovery after diabetic macular edema treatment. Ophthalmol Retina. 2018;2:235\u201343. https:\/\/doi.org\/10.1016\/j.oret.2017.07.003.","journal-title":"Ophthalmol Retina"},{"key":"4986_CR22","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1016\/j.survophthal.2026.04.004","volume":"71","author":"MV Cicinelli","year":"2026","unstructured":"Cicinelli MV, Frizziero L, Sarao V, Cennamo G, Marsico S, Di Fino S, et al. Optical coherence tomography biomarkers in patients with diabetic macular edema treated with dexamethasone implants. Surv Ophthalmol. 2026;71:1631\u201340. https:\/\/doi.org\/10.1016\/j.survophthal.2026.04.004.","journal-title":"Surv Ophthalmol"},{"key":"4986_CR23","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.3390\/jcm12041303","volume":"12","author":"E Costanzo","year":"2023","unstructured":"Costanzo E, Giannini D, De Geronimo D, Fragiotta S, Varano M, Parravano M. Prognostic imaging biomarkers in diabetic macular edema eyes treated with intravitreal dexamethasone implant. J Clin Med. 2023;12:1303 https:\/\/doi.org\/10.3390\/jcm12041303.","journal-title":"J Clin Med"},{"key":"4986_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-35286-2","volume":"13","author":"M Hein","year":"2023","unstructured":"Hein M, Vukmirovic A, Constable IJ, Raja V, Athwal A, Freund KB, et al. Angiographic biomarkers are significant predictors of treatment response to intravitreal aflibercept in diabetic macular edema. Sci Rep. 2023;13:8128. https:\/\/doi.org\/10.1038\/s41598-023-35286-2.","journal-title":"Sci Rep"},{"key":"4986_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-84553-7","volume":"11","author":"C-H Huang","year":"2021","unstructured":"Huang C-H, Yang C-H, Hsieh Y-T, Yang CM, Ho TC, Lai TT. Hyperreflective foci in predicting the treatment outcomes of diabetic macular oedema after anti-vascular endothelial growth factor therapy. Sci Rep. 2021;11:5103. https:\/\/doi.org\/10.1038\/s41598-021-84553-7.","journal-title":"Sci Rep"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04986-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04986-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04986-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T12:14:23Z","timestamp":1792325663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04986-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,18]]},"references-count":25,"alternative-id":["4986"],"URL":"https:\/\/doi.org\/10.1038\/s41433-026-04986-0","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,18]]},"assertion":[{"value":"6 September 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Prof Borrelli is a member of the Eye editorial board.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}